What this market covers
Needles, drills and kits used to take bone samples for diagnosis of cancer, infection and bone disease. Users are radiologists, orthopedic surgeons and pathologists.
Typical segments
- Core needle kits
- Powered bone biopsy drills
- Open biopsy instruments
- Image guided biopsy systems
Source: Eurostat
Why this market is moving now
- Extra-EU import value moved +51% from 2020 to 2025, a direct read on EU demand for sourced supply.
- Supply is concentrated: one country provided a large share of extra-EU imports in 2025.
- US employment in the core industry shifted +4% since 2020.
Key figures
Each figure names the source it came from. Open the source list below to read the quoted line.
| Figure | Value | Year | Source |
|---|---|---|---|
| The EU imported €6.14 billion of products under CN code 90183900 (Needles, catheters, cannulae and the like, used in medical, surgical, dental or) from outside the EU in 2025. | 6.14 EUR billion | 2025 | Eurostat |
| Extra-EU imports of CN 90183900 were up 51% in 2025 compared with 2020 (€4.06 billion), calculated from Eurostat values. | +51 % change | 2025 | Eurostat |
| EU exports of CN 90183900 to countries outside the EU were worth €8.03 billion in 2025. | 8.03 EUR billion | 2025 | Eurostat |
| Trade between EU member states in CN 90183900 (intra-EU arrivals) came to €10.55 billion in 2025. | 10.55 EUR billion | 2025 | Eurostat |
| United States was the largest non-EU supplier of CN 90183900 to the EU in 2025, with €1.97 billion, or 32% of extra-EU imports. | 1.97 EUR billion | 2025 | Eurostat |
| EU exports of CN 90183900 to the United States were €3.55 billion in 2025. | 3.55 EUR billion | 2025 | Eurostat |
| The average value of extra-EU imports of CN 90183900 was €84.50 per kilogram in 2025, calculated from Eurostat value and weight. | 84.50 EUR per kg | 2025 | Eurostat |
| Ireland was the largest EU exporter of CN 90183900 to non-EU countries in 2025, at €3.40 billion. | 3.40 EUR billion | 2025 | Eurostat |
| The EU had 63,227 enterprises in NACE class C3250 (Manufacture of medical and dental instruments and supplies) in 2023. | 63,227 enterprises | 2023 | Eurostat |
| EU enterprises in NACE class C3250 had net turnover of €105.31 billion in 2021. | 105.31 EUR billion | 2021 | Eurostat |
| NACE class C3250 employed 600,000 people across the EU in 2023. | 600,000 persons employed | 2023 | Eurostat |
| The US had 4,547 private establishments in NAICS 339112 (Surgical and medical instrument manufacturing) in 2025. | 4,547 establishments | 2025 | U.S. Bureau of Labor Statistics |
| NAICS 339112 employed an average of 140,413 people in US private industry in 2025. | 140,413 jobs | 2025 | U.S. Bureau of Labor Statistics |
| US employment in NAICS 339112 changed by +4% between 2020 (135,655 jobs) and 2025, calculated from BLS figures. | +4 % change | 2025 | U.S. Bureau of Labor Statistics |
| Average annual pay in US NAICS 339112 was $109,475 in 2025. | 109,475 USD per year | 2025 | U.S. Bureau of Labor Statistics |
| The FDA has recorded 5 510(k) clearances for devices named "bone biopsy needle". | 5 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Angiomed U.S., Inc. holds 1 510(k) clearances for devices named "bone biopsy needle". | 1 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Cook Incorporated holds 1 510(k) clearances for devices named "bone biopsy needle". | 1 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Manan Medical Products, Inc. holds 1 510(k) clearances for devices named "bone biopsy needle". | 1 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Minrad, Inc. holds 1 510(k) clearances for devices named "bone biopsy needle". | 1 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Promex, Inc. holds 1 510(k) clearances for devices named "bone biopsy needle". | 1 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| PubMed indexed 134 papers mentioning "bone biopsy" in the title or abstract in 2025. | 134 papers | 2025 | U.S. National Library of Medicine |
Sources and method
The figures on this page come from the public sources listed below. Read how we work.
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
Quoted lines
- Figure 1
DS-045409, reporter EU27_2020, product 90183900, partner EXT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 6135207496
- Figure 2
DS-045409, reporter EU27_2020, product 90183900, flow import, 2020 VALUE_IN_EUROS 4063352049; 2025 VALUE_IN_EUROS 6135207496
- Figure 3
DS-045409, reporter EU27_2020, product 90183900, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 8032629836
- Figure 4
DS-045409, reporter EU27_2020, product 90183900, partner INT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 10545156208
- Figure 5
DS-045409, reporter EU27_2020, product 90183900, partner US, flow import, 2025, VALUE_IN_EUROS 1973619788
- Figure 6
DS-045409, reporter EU27_2020, product 90183900, partner US, flow export, 2025, VALUE_IN_EUROS 3553875473
- Figure 7
DS-045409, reporter EU27_2020, product 90183900, flow import, 2025, VALUE_IN_EUROS 6135207496, QUANTITY_IN_100KG 726095
- Figure 1
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
Quoted lines
- Figure 8
DS-045409, reporter IE, product 90183900, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 3397650660
- Figure 8
- Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
Quoted lines
- Figure 9
sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs ENT_NR, 2023, 63227
- Figure 10
sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs NETTUR_MEUR, 2021, 105308
- Figure 11
sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs EMP_NR, 2023, 600000
- Figure 9
- U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 339112, 2025 (2026-11-04)
Quoted lines
- Figure 12
QCEW 2025 annual, US000, private, NAICS 339112, annual_avg_estabs 4547
- Figure 13
QCEW 2025 annual, US000, private, NAICS 339112, annual_avg_emplvl 140413
- Figure 14
QCEW 2020 annual_avg_emplvl 135655; 2025 annual_avg_emplvl 140413
- Figure 15
QCEW 2025 annual, US000, private, NAICS 339112, avg_annual_pay 109475
- Figure 12
- U.S. Food and Drug Administration: openFDA 510(k) clearances, device_name "bone biopsy needle" (2026-11-04)
Quoted lines
- Figure 16
openFDA device/510k device_name:"bone biopsy needle", sum of counts by decision_date = 5
- Figure 16
- U.S. Food and Drug Administration: openFDA 510(k) clearances by applicant, device_name "bone biopsy needle" (2026-11-04)
Quoted lines
- Figure 17
applicant.exact "Angiomed U.S., Inc." count 1
- Figure 18
applicant.exact "Cook Incorporated" count 1
- Figure 19
applicant.exact "Manan Medical Products, Inc." count 1
- Figure 20
applicant.exact "Minrad, Inc." count 1
- Figure 21
applicant.exact "Promex, Inc." count 1
- Figure 17
- U.S. National Library of Medicine: PubMed search "bone biopsy"[tiab] AND 2025[dp] (2026-11-04)
Quoted lines
- Figure 22
esearch count 134
- Figure 22
Buyers and suppliers
Who buys
- Hospitals
- Interventional radiologists
- Orthopedic surgeons
Large non-EU suppliers to the EU
Companies to watch
Angiomed U.S., Inc.
1 FDA 510(k) clearances for devices named "bone biopsy needle".
Cook Incorporated
1 FDA 510(k) clearances for devices named "bone biopsy needle".
Manan Medical Products, Inc.
1 FDA 510(k) clearances for devices named "bone biopsy needle".
Minrad, Inc.
1 FDA 510(k) clearances for devices named "bone biopsy needle".
Promex, Inc.
1 FDA 510(k) clearances for devices named "bone biopsy needle".
What the full report covers
- 01Executive summary
The answer in one page: size, direction and what moves it - 02Market definition and scope
What is in and out of the European Union market - 03Market size, 2021 to 2025
Historical series and growth rates - 04Outlook to 2031
Base, low and high scenarios with stated assumptions - 05Rules, policy and deadlines
Regulation and programmes that change demand - 06Drivers and barriers
What accelerates or slows adoption, by customer segment - 07Prices, costs and margins
Unit economics where public data allows - 08Competitive landscape
8 to 12 company profiles with recent moves - 09Opportunities and risks
For new entrants, suppliers and investors - 10Method and sources
Every assumption and source, listed
Included with the full report
- PDF report, 40 to 60 pages
- Excel data pack
- Ready-to-use charts
- Method note and assumptions
- Written to order in 5 working days
Frequently asked questions
How big is the EU bone biopsy market?
There is no single official market total. Eurostat trade data shows the EU imported €6.14 billion of goods under CN 90183900 from outside the EU in 2025 and exported €8.03 billion.
Where does the EU import bone biopsy from?
United States was the largest non-EU supplier in 2025. Other large suppliers included Mexico, Costa Rica, China.
What is the average import price of bone biopsy in the EU?
Dividing Eurostat import value by weight gives about €84.50 per kilogram for CN 90183900 in 2025.
Which EU countries export the most bone biopsy?
Ireland led EU exports to non-EU countries in 2025, followed by Netherlands, Germany.
How many bone biopsy devices are cleared by the FDA?
openFDA lists 5 510(k) clearances for devices named bone biopsy needle.
Which companies hold the most FDA clearances for bone biopsy?
By 510(k) count: Angiomed U.S., Inc., Cook Incorporated, Manan Medical Products, Inc., Minrad, Inc..
Free sample
Get a free sample of this report
We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.
- Full table of contents
- Two sample chapters
- Method note and data outline